Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen Favorable GTN Adjustments Related to Prior Period Sales by Year
Favorable GTN Adjustments Related to Prior Period Sales (legacy disclosure) ($M) ($M)
Amgen Favorable GTN Adjustments Related to Prior Period Sales: $0M in FY2020. No newer figure appears in the documents we track.
Where the FY2020 figure comes from
Source: Form 10-K (filed 2021-02-09) ↗
Reported in Form 10-Q / 10-K Revenue Recognition Footnote (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Favorable GTN Adjustments Related to Prior Period Sales (legacy disclosure) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 0 | – | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | 0 | – | Form 10-K (filed 2019-02-13) ↗ |
Cite this data
StockData. (2026). Amgen Favorable GTN Adjustments Related to Prior Period Sales ($M), annual FY2018–FY2020 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/gtn-prior-adj
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.